| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |